A comprehensive view of moderna inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Chile confirms first human case of bird flu as global spread of H5N1 virus raises concerns; vaccine makers, including GSK and Moderna, developing shots to prevent pandemic
Published:
March 31, 2023
by Medical Daily
|
Moderna to establish US$500M mRNA vaccine facility in Kenya, boosting Africa's medical industry; facility will produce up to 500 million doses annually for acute infections and diseases like HIV, Zika, and Ebola
Published:
March 30, 2023
by AFP World News
|
Moderna CEO defends company’s plans to hike cost of its COVID-19 vaccine from less than US$30 per dose to US$130 per dose later this year in Senate hearing; senators criticized the move, noting US invested nearly US$2.0B to develop the vaccine
Published:
March 27, 2023
by Huntington Herald-Press (IN)
|
Moderna to host fourth annual Virtual Vaccines Day on April 11, 2023 at 8 a.m. ET for analysts and investors; Vaccines Day will include presentations from management and opinion leaders on Moderna's mRNA vaccines and considerations for vaccine development
Published:
March 24, 2023
by Moderna Inc.
|
Moderna and Generation Bio partner to develop non-viral genetic medicines using Generation Bio's proprietary stealth cell-targeted lipid nanoparticle delivery system; Moderna to develop two immune cell programs and two liver programs
Published:
March 23, 2023
by Moderna Inc.
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count